Metadata
| Authors/Creators: |
|
|---|---|
| Commentary on: | McCarthy, EM, Sutton, E, Nesbit, S et al. (18 more authors) (2017) The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. Rheumatology, 56 (6). pp. 1041-1043. ISSN 1462-0324 |
| Dates: |
|
| Institution: | The University of Leeds |
| Depositing User: | Symplectic Publications |
| Date Deposited: | 25 Sep 2018 14:53 |
| Last Modified: | 25 Sep 2018 15:04 |
| Status: | Published |
| Publisher: | Oxford University Press |
| Identification Number: | https://doi.org/10.1093/rheumatology/kex218 |
Commentary/Response Threads
-
McCarthy, EM, Sutton, E, Nesbit, S, Parker, B, Jayne, D, Griffiths, B, Isenberg, DA, Rahman, A, Gordon, C, D’Cruz, DP, Rhodes, B, Lanyon, P, Vital, EM, Yee, C-S, Edwards, CJ, Teh, L-S, Akil, M, McHugh, NJ, Zoma, A, Bruce, IN and British Isles Lupus Assessment Group Biologics Register
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. (deposited 25 Sep 2018 15:05)
- McCarthy, EM, Sutton, E, Nesbit, S, Parker, B, Jayne, D, Griffiths, B, Isenberg, DA, Rahman, A, Gordon, C, D’Cruz, DP, Rhodes, B, Lanyon, P, Vital, EM, Yee, C-S, Edwards, CJ, Teh, L-S, Akil, M, McHugh, NJ, Zoma, A, Bruce, IN and British Isles Lupus Assessment Group Biologics Register Corrigendum: The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. (deposited 25 Sep 2018 14:53) [Currently Displayed]
CORE (COnnecting REpositories)
CORE (COnnecting REpositories)